This process not only aids in the effective control of blood sugar levels in individuals with type 2 diabetes, but also slows gastric emptying, contributing to reduced appetite and potential weight loss in patients
Note that semaglutide is very similar to GLP-1 and its mechanism of action is therefore limited to the activation of the receptor for this hormone, while tirzepatide is made up of an amalgam of amino acids found both in the GLP-1 (yellow circles), GIP (blue circles), and in the two hormones (green circles), which gives it a double agonist activity, capable of activating both receptors for these hormones
While many people have found success with GLP-1s, others whove taken these diabetes and weight loss medications have experienced severe side effects
Focus during this month should be on establishing healthy eating patterns and staying hydrated
A documented trial typically means at least 3 months of use with less than 5% total body weight loss
doi: 10.1210/clinem/dgz069 130 FDA Briefing Document, Endocrinologic and Metabolic Drugs Advisory Committee Meeting (EMDA) (2017)
